Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
| Molecular Profile | MDM2 amp |
| Therapy | N/A |
| Indication/Tumor Type | parosteal osteosarcoma |
| Response Type | not applicable |
| Molecular Profile | Indication/Tumor Type | Response Type | Therapy Name | Approval Status | Evidence Type | Efficacy Evidence | References |
|---|---|---|---|---|---|---|---|
| MDM2 amp | parosteal osteosarcoma | not applicable | N/A | Clinical Study | Diagnostic | MDM2 amplification aids in the diagnosis of parosteal osteosarcoma (PMID: 33799733, PMID: 24786129, PMID: 21336260, PMID: 20601938). | 20601938 33799733 24786129 21336260 |
| PubMed Id | Reference Title | Details |
|---|---|---|
| (33799733) | MDM2 Amplified Sarcomas: A Literature Review. | Full reference... |
| (24786129) | Parosteal osteosarcoma. | Full reference... |
| (21336260) | MDM2 and CDK4 immunohistochemistry is a valuable tool in the differential diagnosis of low-grade osteosarcomas and other primary fibro-osseous lesions of the bone. | Full reference... |
| (20601938) | Immunohistochemical analysis of MDM2 and CDK4 distinguishes low-grade osteosarcoma from benign mimics. | Full reference... |